日本ケミファ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2016/03/04 | 日証協 | 174,409株 | +3.1% | 0株 | 0% | 238,967株 | +0.77% | 1,820株 | +82% |
2016/02/26 | 日証協 | 169,163株 | -13.01% | 0株 | -100% | 237,147株 | -0.84% | 1,000株 | -99.32% |
2016/02/19 | 日証協 | 194,453株 | +192.62% | 146,000株 | +3550% | 239,147株 | +111.06% | 147,000株 | +7250% |
2016/02/12 | 日証協 | 66,453株 | +31.71% | 4,000株 | -87.88% | 113,306株 | +0.89% | 2,000株 | -91.67% |
2016/02/05 | 日証協 | 50,453株 | +19.66% | 33,000株 | -8.33% | 112,307株 | +2.74% | 24,000株 | -49.24% |
2016/01/29 | 日証協 | 42,163株 | -16.43% | 36,000株 | +1700% | 109,308株 | +9.15% | 47,278株 | +2089.81% |
2016/01/22 | 日証協 | 50,453株 | +4.01% | 2,000株 | -33.33% | 100,149株 | -9.9% | 2,159株 | -28.03% |
2016/01/15 | 日証協 | 48,507株 | +2.1% | 3,000株 | -85.13% | 111,149株 | +8.81% | 3,000株 | -87.85% |
2016/01/08 | 日証協 | 47,507株 | +81.21% | 20,180株 | 0% | 102,149株 | +12.07% | 24,693株 | +154.75% |
2015/12/30 | 日証協 | 26,217株 | -40.71% | 0株 | 0% | 91,149株 | -8.99% | 9,693株 | -35.38% |
2015/12/25 | 日証協 | 44,217株 | -10.69% | 0株 | -100% | 100,149株 | 0% | 15,000株 | -21.05% |
2015/12/18 | 日証協 | 49,507株 | -9.17% | 19,000株 | +35.19% | 100,149株 | +13.2% | 19,000株 | -39.76% |
2015/12/11 | 日証協 | 54,507株 | -27.74% | 14,054株 | +51.28% | 88,470株 | +1.52% | 31,541株 | +688.33% |
2015/12/04 | 日証協 | 75,430株 | +2.72% | 9,290株 | -48.39% | 87,148株 | -20.16% | 4,001株 | -63.63% |
2015/11/27 | 日証協 | 73,430株 | +32.47% | 18,000株 | +146.91% | 109,148株 | +7.91% | 11,000株 | +22.22% |
2015/11/20 | 日証協 | 55,430株 | -31.69% | 7,290株 | -59.5% | 101,148株 | -10.61% | 9,000株 | -58.54% |
2015/11/13 | 日証協 | 81,140株 | -6.89% | 18,000株 | -67.27% | 113,148株 | -8.86% | 21,710株 | +14.26% |
2015/11/06 | 日証協 | 87,140株 | -14.69% | 55,000株 | +52.78% | 124,148株 | -0.8% | 19,000株 | -53.66% |
2015/10/30 | 日証協 | 102,140株 | +3.03% | 36,000株 | +56.52% | 125,148株 | -3.84% | 41,000株 | +1950% |
※株式分割は考慮していませんのでご注意ください。